Journal Mobile Options
Table of Contents
Vol. 71, No. 2, 2009
Issue release date: April 2009
ORL 2009;71:78–86
(DOI:10.1159/000189783)

Ménière’s Disease Is a Viral Neuropathy

Gacek R.R.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Morphological and clinical evidence supports a viral neuropathy in Ménière’s disease (MD). Quantitative examination of 11 sectioned temporal bones (TBs) from 8 patients with a history of MD revealed a significant loss of vestibular ganglion cells in both the endolymph hydropic (EH) and non-EH ears. Transmission electron microscopy of vestibular ganglion cells excised from a patient with MD revealed viral particles enclosed in transport vesicles. Antiviral treatment controlled vertigo in 73 of 86 patients with vestibular neuronitis (85%) and 32 of 35 patients with MD (91%).



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Hallpike CS, Cairns H: Observations on the pathology of Ménière’s syndrome. J Laryngol Otol 1938;53:625–655.

    External Resources

  2. Yamakawa K: Über die pathologische Veränderung bei einem Ménière-Kranken. J Otorhinolaryngol Soc Jpn 1938;44:2310–2312.
  3. Kimura RS, Schuknecht HF: Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac. Pract Otorhinolaryngol 1965;27:343–354.
  4. Schuknecht HF, Northrop C, Igarashi M: Cochlear pathology after destruction of the endolymphatic sac in the cat. Acta Otolaryngol 1968;65:479–487.
  5. Kimura RS: Animal models of endolymphatic hydrops. Am J Otolaryngol 1982;3:447–451.
  6. Swart JG, Schuknecht HF: Long term effects of destruction of the endolymphatic sac in a primate species. Laryngoscope 1988;98:1183–1189.
  7. Schuknecht HF: Pathology of the Ear, ed 2. Philadelphia, Lea & Febiger, 1993.
  8. Nadol JB: Positive Hennebert’s sign in Ménière’s Disease. Arch Otolaryngol 1977;103:524–530.

    External Resources

  9. Wittmaack K: Die entzündlichen Erkrankungsprozesse des Gehörorganes; in Wittmaack K (ed): Handbuch der speziellen pathologischen Anatomie und Histologie. Berlin, Springer, 1926, pp 102–379.
  10. Merchant S, Adams JC, Nadol JB: Pathophysiology of Ménière’s syndrome: are symptoms caused by endolymphatic hydrops. Otol Neurotol 2005;26:74–81.
  11. Herriott RM: Infectious nucleic acids, a new dimension in virology. Science 1961;134:256–260.
  12. Meier JL, Straus SE: Comparative biology of latent varicella zoster virus and herpes simplex virus infections. J Infect Dis 1992:166(suppl):S13–S23.
  13. Sadzot-Delvaux C, Baudoux L, Defechereux P, Piette J, Rentier B: Overview of the replication cycle of varicella-zoster virus; in Wolff MH, Schunemann A, Schmidt A (eds): Varicella-Zoster Virus. Molecular Biology, Pathogenesis and Clinical Aspects. Contrib Microbiol. Basel, Karger, 1999, vol 3, pp 21–42.
  14. Arnold W, Niedermeyer HP: Herpes simplex virus antibodies in the perilymph of patients with Ménière’s disease. Arch Otolaryngol Head Neck Surg 1997;123:53–56.
  15. Pitovski DZ, Robinson AM, Garcia-Ibanez E, et al: Presence of HSV-1 gene products characteristic of active infection in the vestibular ganglia of patients diagnosed with acute Ménière’s disease. 22nd Annu Midwinter Research Meeting, Association for Research in Otolaryngology, St. Petersburg Beach, 1999.
  16. Vrabec JT: Herpes simplex virus and Ménière’s disease. Laryngoscope 2003;113:1431–1438.
  17. Richter E: Quantitative study of human Scarpa’s ganglion and vestibular sensory epithelia. Acta Otolaryngol 1980;90:199–208.
  18. Velázquez-Villaseñor L, Merchant SN, Tsuji K, Glynn RJ, Wall C 3rd, Rauch SD: Temporal bone studies of the human peripheral vestibular system. Normative Scarpa’s ganglion cell data. Ann Otol Rhinol Laryngol Suppl 2000;181:14–19.

    External Resources

  19. Gacek RR: On the duality of the facial nerve ganglion. Laryngoscope 1998;108:1077–1086.
  20. Gacek RR, Gacek MR: Ménière’s disease as a manifestation of vestibular ganglionitis. Am J Otolaryngol 2001;22:241–250.
  21. Gacek RR: Evidence for viral neuropathy in recurrent vertigo. ORL 2008;70:6–15.

    External Resources

  22. Davis GL: Cytomegalovirus in the inner ear. Case report and electron microscopic study. Ann Otol Rhinol Laryngol 1969;78:1178–1188.
  23. Gacek RR: The pathology of facial and vestibular neuronitis. Am J Otolaryngol 1999;20:202–210.
  24. Denny-Brown D, Adams RD, Fitzgerald PJ: Pathologic features of herpes zoster. A note on geniculate herpes. Arch Neurol Psychiatry 1949;51:216–231.
  25. Gacek RR, Schoonmaker JE: Morphologic changes in the vestibular nerves and nuclei following labyrinthectomy in the cat: a case for the neurotrophin hypotheses in vestibular compensation. Acta Otolaryngol 1997;117:244–249.
  26. Schuknecht HF: Delayed endolymphatic hydrops. Ann Otol Rhinol Laryngol 1978;87:743–748.
  27. Schuknecht HF, Suzuka Y, Zimmerman C: Delayed endolymphatic hydrops and its relationship to Ménière’s disease. Ann Otol Rhinol Laryngol 1990;99:843–853.
  28. Sawtell NM: The probability of in vivo reactivation of herpes simplex virus increases with the number of latently infected neurons in the ganglia. J Virol 1998;72:6888–6892.
  29. Dickins JR, Graham SS: Ménière’s disease – 1983–1989. Am J Otol 1990;11:51–65.
  30. Stahle J, Friberg N, Svedberg A: Long-term progression of Ménière’s disease. Am J Otol 1989;10:170–173.
  31. Paparella MM, Griebie MS: Bilaterality of Ménière’s disease. Acta Otolaryngol 1984;97:233–237.
  32. Furuta Y, Takasu T, Fukuda S, et al: Latent herpes simplex virus type I in human vestibular ganglia. Acta Otolaryngol Suppl 1993;503:85–89.
  33. Kuypers HG, Ugolini G: Viruses as trans-neuronal tracers. Trends Neurosci 1990;13:71–75.
  34. Zemanick MC, Strick PL, Dix RD: Direction of transneural transport of herpes simplex virus I in the primate motor system is strain-dependent. Proc Natl Acad Sci USA 1991;88:8048–8051.
  35. LaVail JH, Topp KS, Giblin PA, et al: Factors that contribute to the transneuronal spread of herpes simplex virus. J Neurosci Res 1997;49:485–496.
  36. Card JP: Exploring brain circuitry with neurotropic viruses: new horizons in neuroanatomy. Anat Rec 1998;253:176–185.
  37. Zerhouni EA: US biomedical research: basic translational and clinical sciences. JAMA 2005;294:1332–1348.

    External Resources

  38. Westfall JM, Mold J, Fagnan L: Practice-based research – ‘blue highways’ on the NIH roadmap. JAMA 2007;297:403–406.
  39. Tyring SK, Baker D, Snowden W: Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years experience with acyclovir. J Infect Dis 2002;186(suppl 1):S40–S46.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50